NCT01249027 - XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study | Biotech Hunter

Enrollment

2,605

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions

AngioplastyChronic Coronary OcclusionStent ThrombosisVascular DiseaseMyocardial IschemiaCoronary Artery StenosisCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis

Interventions

DEVICE

XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Patients who receive XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)will be invited to participate in the study.

Trial Locations (1)

95054

Abbott Vascular, Santa Clara